Results 131 to 140 of about 3,598 (185)
Some of the next articles are maybe not open access.

An Evaluation of PUVA-Therapy for Alopecia areata

Dermatologica, 2009
30 patients with alopecia areata were treated with 8-methoxypsoralen orally combined with whole body UVA exposure. 9 patients showed more than 60% regrowth of hair, 8 of them had recurrences of hair loss within a mean time of 7.7 months. No selecting criteria could be found prophesying good results of PUVA therapy.
van der Schaar, W. W.   +1 more
openaire   +3 more sources

PUVA-Bad-Therapie

Der Hautarzt, 1994
Systemic PUVA photochemotherapy is widely used for a variety of skin diseases. Administration of 8-methoxypsoralen in a dilute bathwater solution may be an effective alternative therapy with no systemic side-effects and requiring smaller amounts of UVA to induce the required phototoxic response.
Martina Kerscher   +2 more
openaire   +1 more source

Dose Measurement in PUVA Therapy

Dermatologica, 2009
The dose emitted by the fluorescent tubes used in PUVA therapy is not constant: it varies in function of time, age of the lamps, and several other factors. Exact knowledge of the dose given to the patient requires continuous measurement and integration of the UV-A output.
openaire   +2 more sources

Photoprotection of the eye in PUVA therapy

British Journal of Dermatology, 1978
Photochemotherapy with psoralens, now widely used in the therapy of psoriasis, vitiligo and mycosis fungoides, has been proposed to have the capacity, during long-term therapy, to induce ocular damage, e.g. cataract. This view is based on animal experiments (Cloud, Hakim & Griffin, 1960, 1961; Free-man & Troll, 1969) and as a consequence adequate ...
openaire   +2 more sources

Carcinogenic Risk of Bath PUVA in Comparison to Oral PUVA Therapy

Dermatology, 1999
The potential carcinogenic risk of bath PUVA therapy was compared to that of systemic (oral) PUVA. An analysis of the epidemiological data on cancer risk following bath PUVA with trimethylpsoralen does not support the conclusion that bath PUVA per se is less carcinogenic than systemic PUVA with 8-methoxypsoralen (8-MOP).
Shephard SE, Panizzon RG
openaire   +3 more sources

PUVA therapy.

American family physician, 1991
PUVA is an acronym for psoralen plus ultraviolet-A radiation. This form of photochemical therapy is commonly used in the treatment of psoriasis and vitiligo, but it is also beneficial in other dermatologic diseases. An understanding of psoralen's mechanism of action and the unique properties of the various psoralen preparations is important in ensuring
T N, Helm   +3 more
openaire   +1 more source

PUVA THERAPY OF CHRONIC ACTINIC DERMATITIS

Australasian Journal of Dermatology, 1988
SummaryA modified PUVA regime was used to treat five men with long‐standing chronic actinic dermatitis. They are all now symptom free on monthly maintenance PUVA therapy and no longer react abnormally to ultra‐violet radiation, with consequent improvement of their quality of life.
S E, Sinclair, C, Hindson
openaire   +2 more sources

PUVA therapy of chronic actinic dermatitis

British Journal of Dermatology, 1985
Four men with long-standing chronic actinic dermatitis were treated with a modified PUVA regime which initially included generalized applications of topical steroids given immediately after PUVA exposure. All patients are now free of rash, no longer need protection from UV radiation, and are being maintained on twice monthly PUVA therapy (IO J/cm2).
C, Hindson, J, Spiro, A, Downey
openaire   +2 more sources

Melanocyte changes following PUVA therapy

Journal of the American Academy of Dermatology, 1979
The effect of psoralens and long-wave ultraviolet light (PUVA) therapy on human melanocytes was studied at the ultrastructural level. The results demonstrate an increase in the number of melanocytes, a change in their location, and an increase in the size of the melanosomes.
A S, Zelickson, J H, Mottaz, S A, Muller
openaire   +2 more sources

PUVA therapy of diffuse granuloma annulare

Clinical and Experimental Dermatology, 1988
3 cas de granulome annulaire diffus interessant 20 a 40% de la surface corporelle et de duree variable ont ete traites par la PUVAtherapie.
T C, Hindson, J G, Spiro, H, Cochrane
openaire   +2 more sources

Home - About - Disclaimer - Privacy